Literature DB >> 17627634

Hepatitis B virus genotypes and subgenotypes in China.

Zhanhui Wang1, Yuehua Huang, Shujuan Wen, Bin Zhou, Jinlin Hou.   

Abstract

Eight Hepatitis B virus (HBV) genotypes (A to H) have been identified based on an intergenotype divergence of 8% or more in the entire nucleotide sequence. Subgenotypes have also been identified in different HBV genotypes. As a highly endemic area for HBV infection, the prevalence of chronic HBV infection in China is between 8 and 20% of the general population. Genotypes B and C were identified as the most common HBV strains and account for approximately 95% of Chinese patients. Further study confirmed all genotype B strains belong to subgenotype Ba. Two of genotype C subgenotypes, C1 (Cs) and C2 (Ce), were found in China and they showed different geographic distributions. Genotype A was very rarely found, while genotypes E, F, G and H have not beenreported until now. Two types of HBV C/Drecombinant viruses have been identified in west China and distinct geographic and ethnic distributions were observed. Significant differences were observed (P < 0.001) in the prevalence of A1896 and T1762/A1764 mutations among HBV Ba, C1 and C2 subgenotypes in Chinese patients. Accumulating evidence showed the response rate to antiviral therapy in Chinese patients is higher in genotype B than genotype C patients on interferon treatment, but no difference was observed on nucleoside/nucleotide analog treatment.

Entities:  

Year:  2007        PMID: 17627634     DOI: 10.1111/j.1872-034X.2007.00102.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  23 in total

1.  Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay.

Authors:  Yao Zhao; Xiu-Yu Zhang; Jin-Jun Guo; Ai-Zhong Zeng; Jie-Li Hu; Wen-Xiang Huang; You-Lan Shan; Ai-Long Huang
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

2.  Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.

Authors:  Xiaodong Li; Lin Wang; Yanwei Zhong; Vincent Wai-Sun Wong; Zhihui Xu; Yan Liu; Qinghong Li; Shaojie Xin; Jingmin Zhao; Dongping Xu
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

3.  Relative bioavailability study of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy male fasted volunteers.

Authors:  Chengtao Lu; Yanyan Jia; Jing Yang; Ying Song; Wenxing Liu; Yi Ding; Xiaoli Sun; Aidong Wen
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

4.  HBV serum markers of 49164 patients and their relationships to HBV genotype in Fujian Province of China.

Authors:  Sheng Lin; Can Liu; Hongyan Shang; Huijuan Chen; Bin Yang; Jing Chen; Yong Chen; Dan Chen; Qishui Ou
Journal:  J Clin Lab Anal       Date:  2013-02-19       Impact factor: 2.352

5.  Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication.

Authors:  Jie Wang; Zhong-Wei Xu; Shuang Liu; Rui-Yang Zhang; Shan-Long Ding; Xiao-Meng Xie; Lu Long; Xiang-Mei Chen; Hui Zhuang; Feng-Min Lu
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

6.  Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.

Authors:  Weihua Li; Guangyuan Chen; Xianwen Yu; Yongying Shi; Miaoguan Peng; Jianjun Wei
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

7.  Rapid detection of hepatitis B virus variants associated with lamivudine and adefovir resistance by multiplex ligation-dependent probe amplification combined with real-time PCR.

Authors:  Shuangrong Jia; Feng Wang; Fake Li; Kai Chang; Shaojun Yang; Kejun Zhang; Wenbin Jiang; Ya Shang; Shaoli Deng; Ming Chen
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

8.  Development of a novel DNA sequencing method not only for hepatitis B virus genotyping but also for drug resistant mutation detection.

Authors:  Fanjun Wang; Lili Lu; Changshun Yu; Zhanwu Lv; Xuelian Luo; Chao Wan; Zhaohui Hu; Qinyi Zhu; Youping Deng; Chuyu Zhang
Journal:  BMC Med Genomics       Date:  2013-01-23       Impact factor: 3.063

9.  Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people.

Authors:  Lance K Ching; Prabhu P Gounder; Lisa Bulkow; Philip R Spradling; Michael G Bruce; Susan Negus; Mary Snowball; Brian J McMahon
Journal:  Liver Int       Date:  2016-04-06       Impact factor: 5.828

10.  Mutations in the major hydrophilic region (MHR) of hepatitis B virus genotype C in North China.

Authors:  Ying Shi; Feili Wei; Dongmei Hu; Qing Li; Davey Smith; Ning Li; Dexi Chen
Journal:  J Med Virol       Date:  2012-12       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.